Cube,
I have devised the following acid test for PGDCEBs:
1) Do 75% of the news heads at the bottom
of the Yahoo screen have the following
phrase: "So and So and So, PC, Announce
Class Periods for Security Action Complaints"?
2) Do the posters on the SI and Yahoo message
threads speak of the CEO exclusively by
his first name. I.e.: "If Tom won't listen
to what the shareholders have to say, maybe
he should at least care about his own holdings"?
3) Have those posters resorted to profanity in
which the male reproductive organ of the accused
poster is attached without a hyphen to his head?
3) Do they contain blanket accusations of market-
maker duplicity?
4) Do rumors of an imminent takeover/buyout appear
in those lovely blue private message screens SI provides
the moment you join the thread?
5) Are the thread's self-styled TA wizards
a) guaranteeing the thread that the chart is
currently showing a double-bottom ("Hey, it looks
like a W"), or b) resorting to fractions for time-frames
for Stochastics, RSI, OBV, and CCI studies?
Seriously: This, from Online Investor, sums it up in a nutshell:
"Vivus: Life After Viagra?
May 18, 1998 - The company has recently been sued, watched its share price get decimated, and seen a new competitor introduce a pill that successfully treats impotence with few side effects.
The lawsuit, which is now being treated as a class action, was prompted by shareholders who believe the company manipulated share prices by issuing bullish statements that made things appear better than they actually were during the second half of 1997. Things, in fact, were anything but better. Shareholders point to December 10, 1997, as proof that things were actually not going well at all. On that day, the company announced it would miss fourth quarter revenue
goals by as much as 25 percent; as a result the company's share price, which stood as high as $21.50 on the day the company issued its revenue warning, fell nearly 30 percent, to $13 and change. Since then, shares have retreated even further, resting at its current price of $10. Once upon a time, shares of Vivus traded as high as $41.88."
The sole difference, of course, lying in the phrase, "as a result the company's share price, which stood as high as $21.50 on the day the company issued its revenue warning, fell nearly 30 percent." It should of course be amended to "gapped nearly 30 percent."
Hope that helps,
Ivan |
